This study aims to improve access to genetic testing for people with certain cancers, especially those from minority groups or rural areas who may have limited access to genetic counseling. It compares two ways of providing information about genetic testing: through a computer-generated character called PERLA, or through a human genetics healthcare provider. The study wants to see if PERLA can help more patients get genetic testing within three months of starting their cancer care. You may be able to join if you are over 18 and have breast cancer (including male breast cancer, triple-negative, or diagnosed before age 50), ovarian cancer, pancreatic cancer, or metastatic (spread to other parts of the body) or high-risk prostate cancer.

Study design

This interventional study plans to enroll 800 participants. It compares receiving genetic counseling from a provider to receiving genetics education through an educational intervention.

What's involved

You may participate in focus groups, usability testing with interviews, or be randomized to receive either provider-based genetic counseling or genetics education.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome, genetic testing, is measured up to 3 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.